EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in the Pathogenesis and Treatment of Resistant Hypertension

Jill Dybiec iD, Julia Krzemińska iD, Ewa Radzioch iD, Magdalena Szlagor iD, Magdalena Wronka, Ewelina Młynarska iD, Jacek Rysz, Beata Franczyk

International Journal of Molecular Sciences · 18.08.2023 · 24 (16) · 12911

DOI: 10.3390/ijms241612911 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2023. Verfasst von Jill Dybiec und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Łódź, Poland. Hauptthemen laut MEDLINE: Hypertension. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a prevalent chronic disease associated with an increased risk of cardiovascular (CV) premature death, and its severe form manifests as resistant hypertension (RH). The accurate prevalence of resistant hypertension is difficult to determine due to the discrepancy in data from various populations, but according to recent publications, it ranges from 6% to 18% in hypertensive patients. However, a comprehensive understanding of the pathogenesis and treatment of RH is essential. This review emphasizes the importance of identifying the causes of treatment resistance in antihypertensive therapy and highlights the utilization of appropriate diagnostic methods. We discussed innovative therapies such as autonomic neuromodulation techniques like renal denervation (RDN) and carotid baroreceptor stimulation, along with invasive interventions such as arteriovenous anastomosis as potential approaches to support patients with inadequate medical treatment and enhance outcomes in RH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHumansTherapies, InvestigationalKidneyAutonomic Nervous System

Stichwörter der Autor:innen

antihypertensive drugsblood pressure measurementhypertensionrenal denervationresistant hypertensionsecondary hypertension

Autor:innen und Institutionen

  • Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Łódź, Poland.
  • Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Żeromskiego 113, 90-549 Łódź, Poland.

ORCID-Profile: Jill Dybiec, Julia Krzemińska, Ewa Radzioch, Magdalena Szlagor, Ewelina Młynarska

Zitieren

APA

Dybiec, J., Krzemińska, J., Radzioch, E., Szlagor, M., Wronka, M., Młynarska, E., Rysz, J., & Franczyk, B. (2023). Advances in the Pathogenesis and Treatment of Resistant Hypertension. International Journal of Molecular Sciences, 24(16), 12911. https://doi.org/10.3390/ijms241612911

Vancouver

Dybiec J, Krzemińska J, Radzioch E, Szlagor M, Wronka M, Młynarska E, et al. Advances in the Pathogenesis and Treatment of Resistant Hypertension. International Journal of Molecular Sciences. 2023;24(16):12911. doi:10.3390/ijms241612911

BibTeX
@article{Dybiec2023,
  author = {Dybiec, Jill and Krzemińska, Julia and Radzioch, Ewa and Szlagor, Magdalena and Wronka, Magdalena and Młynarska, Ewelina and Rysz, Jacek and Franczyk, Beata},
  title = {Advances in the Pathogenesis and Treatment of Resistant Hypertension},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12911},
  doi = {10.3390/ijms241612911}
}
Kostenlos starten →